Browse > Article
http://dx.doi.org/10.4062/biomolther.2013.103

Enhanced Anti-Cancer Effect of Snake Venom Activated NK Cells on Lung Cancer Cells by Inactivation of NF-κB  

Kollipara, Pushpa Saranya (College of Pharmacy and Medical Research Center, Chungbuk National University)
Won, Do Hee (College of Pharmacy and Medical Research Center, Chungbuk National University)
Hwang, Chul Ju (College of Pharmacy and Medical Research Center, Chungbuk National University)
Jung, Yu Yeon (College of Pharmacy and Medical Research Center, Chungbuk National University)
Yoon, Heui Seoung (College of Pharmacy and Medical Research Center, Chungbuk National University)
Park, Mi Hee (College of Pharmacy and Medical Research Center, Chungbuk National University)
Song, Min Jong (Department of Obstetrics and Gynecology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Song, Ho Sueb (College of Korean Medicine, Gachon University)
Hong, Jin Tae (College of Pharmacy and Medical Research Center, Chungbuk National University)
Publication Information
Biomolecules & Therapeutics / v.22, no.2, 2014 , pp. 106-113 More about this Journal
Abstract
In the present study, we investigated anti-cancer effect of snake venom activated NK cells (NK-92MI) in lung cancer cell lines. We used snake venom ($4{\mu}g/ml$) treated NK-92MI cells to co-culture with lung cancer cells. There was a further decrease in cancer cell growth up to 65% and 70% in A549 and NCI-H460 cell lines respectively, whereas 30-40% was decreased in cancer cell growth by snake venom or NK-92MI alone treatment. We further found that the expression of various apoptotic proteins such as that Bax, and cleaved caspase-3 as well as the expression of various death receptor proteins like DR3, DR4 and Fas was also further increased. Moreover, consistent with cancer cell growth inhibition, the DNA binding activity of NF-${\kappa}B$ was also further inhibited after treatment of snake venom activated NK-92MI cells. Thus, the present data showed that activated NK cells could further inhibit lung cancer cell growth.
Keywords
NK-92MI cells; Lung cancer; Snake venom; Death receptor; NF-${\kappa}B$;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Yoshida, T., Horinaka, M. and Sakai, T. (2010) "Combination-oriented molecular-targeting prevention" of cancer: a model involving the combination of TRAIL and a DR5 inducer. Environ. Health Prev. Med. 15, 203-210.   DOI
2 Zhang, H. P., Takayama, K., Su, B., Jiao, X. D., Li, R. and Wang, J. J. (2011) Effect of sunitinib combined with ionizing radiation on endothelial cells. J. Radiat. Res. 52, 1-8.   DOI   ScienceOn
3 Sancho-Martinez, I. and Martin-Villalba, A. (2009) Tyrosine phosphorylation and CD95: a FAScinating switch. Cell Cycle 8, 838-842.   DOI
4 Screpanti, V., Wallin, R. P., Grandien, A. and Ljunggren, H. G. (2005) Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol. Immunol. 42, 495-499.   DOI   ScienceOn
5 Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H. and Okumura, K. (2001) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193, 661-670.   DOI
6 Smyth, M. J., Hayakawa, Y., Takeda, K. and Yagita, H. (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2, 850-861.   DOI   ScienceOn
7 Son, D. J., Park, M. H., Chae, S. J., Moon, S. O., Lee, J. W., Song, H. S., Moon, D. C., Kang, S. S., Kwon, Y. E. and Hong, J. T. (2007) Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB. Mol. Cancer Ther. 6, 675-683.
8 Song, J. K., Jo, M. R., Park, M. H., Song, H. S., An, B. J., Song, M. J., Han, S. B. and Hong, J. T. (2012) Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor kappaB and signal transducer and activator of transcription 3. Arch. Pharm. Res. 35, 867-876.   DOI
9 Sun, S. Y. (2011) Understanding the role of the death receptor 5/FADD/caspase-8 death signaling in cancer metastasis. Mol. Cell. Pharmacol. 3, 31-34.
10 Tam, Y. K., Miyagawa, B., Ho, V. C. and Klingemann, H. G. (1999) Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother. 8, 281-290.   DOI   ScienceOn
11 Triller, N., Korosec, P., Kern, I., Kosnik, M. and Debeljak, A. (2006) Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54, 235-240.   DOI   ScienceOn
12 Magne, N., Bay, J. O., Blay, J. Y., Goncalves, A., Massard, C., Thariat, J., Wislez, M., Andre, T. and Vignot, S. (2012) [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view]. Bull. Cancer 99, 1209-1217.
13 Markovic, S. N. and Murasko, D. M. (1991) Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res. 51, 1124-1128.
14 Mohammed, N., Kestin, L. L., Grills, I. S., Battu, M., Fitch, D. L., Wong, C. Y., Margolis, J. H., Chmielewski, G. W. and Welsh, R. J. (2011) Rapid disease progression with delay in treatment of non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 79, 466-472.   DOI   ScienceOn
15 Park, M. H., Choi, M. S., Kwak, D. H., Oh, K. W., Yoon do, Y., Han, S. B., Song, H. S., Song, M. J. and Hong, J. T. (2011) Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB. Prostate 71, 801-812.   DOI   ScienceOn
16 Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr. and Sledge, G. W., Jr. (1997) Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17, 3629-3639.   DOI
17 O'Donovan, T. R., O'Sullivan, G. C. and McKenna, S. L. (2011) Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7, 509-524.   DOI
18 Park, H. J., Lee, S. H., Son, D. J., Oh, K. W., Kim, K. H., Song, H. S., Kim, G. J., Oh, G. T., Yoon, D. Y. and Hong, J. T. (2004) Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 50, 3504-3515.   DOI   ScienceOn
19 Park, M. H., Jo, M., Won, D., Song, H. S., Han, S. B., Song, M. J. and Hong, J. T. (2012a) Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression. BMC Cancer 12, 228.   DOI
20 Park, M. H., Son, D. J., Kwak, D. H., Song, H. S., Oh, K. W., Yoo, H. S., Lee, Y. M., Song, M. J. and Hong, J. T. (2009) Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch. Pharm. Res. 32, 1545-1554.   과학기술학회마을   DOI
21 Park, M. H., Song, M. J., Cho, M. C., Moon, D. C., Yoon do, Y., Han, S. B. and Hong, J. T. (2012b) Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. Immunology 135, 63-72.   DOI   ScienceOn
22 Kang, Y. J., Kim, I. Y., Kim, E. H., Yoon, M. J., Kim, S. U., Kwon, T. K. and Choi, K. S. (2011) Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. Exp. Mol. Med. 43, 24-34.   과학기술학회마을   DOI
23 Inoue, N., Matsuda, F., Goto, Y. and Manabe, N. (2011) Role of cell-death ligand-receptor system of granulosa cells in selective follicular atresia in porcine ovary. J. Reprod. Dev. 57, 169-175.   DOI   ScienceOn
24 Jahangeer, S., Forde, P., Soden, D. and Hinchion, J. (2013) Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours. Cancer Treat. Rev. 39, 862-871.   DOI   ScienceOn
25 Jo, M., Park, M. H., Kollipara, P. S., An, B. J., Song, H. S., Han, S. B., Kim, J. H., Song, M. J. and Hong, J. T. (2012) Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol. Appl. Pharmacol. 258, 72-81.   DOI   ScienceOn
26 Karin, M. and Lin, A. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
27 Latz, C., Huang, Q., Kapadia, M. K. and Freitag, S. K. (2009) Metastasis to eyelid as initial presentation of non-small cell carcinoma. Ophthal. Plast. Reconstr. Surg. 25, 406-408.   DOI   ScienceOn
28 Bae, J. H., Kim, J. Y., Kim, M. J., Chang, S. H., Park, Y. S., Son, C. H., Park, S. J., Chung, J. S., Lee, E. Y., Kim, S. H. and Kang, C. D. (2010) Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother. 33, 391-401.   DOI
29 Brady, J., Carotta, S., Thong, R. P., Chan, C. J., Hayakawa, Y., Smyth, M. J. and Nutt, S. L. (2010) The interactions of multiple cytokines control NK cell maturation. J. Immunol. 185, 6679-6688.   DOI
30 Bae, J. H., Kim, S. J., Kim, M. J., Oh, S. O., Chung, J. S., Kim, S. H. and Kang, C. D. (2012) Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction. Cancer Sci. 103, 7-16.   DOI   ScienceOn
31 Burke, S., Lakshmikanth, T., Colucci, F. and Carbone, E. (2010) New views on natural killer cell-based immunotherapy for melanoma treatment. Trends Immunol. 31, 339-345.   DOI   ScienceOn
32 Cerwenka, A. and Lanier, L. L. (2001) Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1, 41-49.   DOI   ScienceOn
33 Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A. (2001) The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640.   DOI   ScienceOn
34 Du, G., Ye, L., Zhang, G., Dong, Q., Liu, K. and Tian, J. (2012) Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-gamma production. J. Cancer Res. Clin. Oncol. 138, 1727-1736.   DOI   ScienceOn
35 Elrod, H. A. and Sun, S. Y. (2008) Modulation of death receptors by cancer therapeutic agents. Cancer Biol. Ther. 7, 163-173.   DOI   ScienceOn
36 Glas, R., Franksson, L., Une, C., Eloranta, M. L., Ohlen, C., Orn, A. and Karre, K. (2000) Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191, 129-138.   DOI
37 Badr, G., Al-Sadoon, M. K. and Rabah, D. M. (2013) Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models. Free Radic. Biol. Med. 65, 175-189.   DOI
38 Hercend, T., Farace, F., Baume, D., Charpentier, F., Droz, J. P., Triebel, F. and Escudier, B. (1990) Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma. J. Biol. Response Mod. 9, 546-555.
39 Al-Sadoon, M. K., Rabah, D. M. and Badr, G. (2013) Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction. Cell. Immunol. 284, 129-138.   DOI   ScienceOn
40 Ashkenazi, A. (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 19, 325-331.   DOI   ScienceOn
41 Baud, V. and Karin, M. (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40.   DOI   ScienceOn
42 Yasumura, S., Amoscato, A., Hirabayashi, H., Lin, W. C. and Whiteside, T. L. (1994) Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck. Cancer Immunol. Immunother. 39, 407-415.   DOI
43 Karin, M. and Greten, F. R. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.   DOI   ScienceOn